A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma

Figure 5

Survival analysis results and multiple ROC results. (a–c) The survival analysis of TCGA-LIHC cohort, GSE76427 cohort, and ICGC-LIRI cohort, respectively. (d–f) Multiple ROC results in 1 year, 3 years, and 5 years, respectively.

(a)

(b)

(c)

(d)

(e)

(f)